Weave Bio
AI for Science · Drug Discovery AI
$30Mtotal raised · 2 rounds on record
2hiring now · open roles
$20Mlatest round · Series A · Oct 2025 · 12 mo ago
3backers · Ground Up Ventures, Innovation Endeavors
Overview
Weave Bio is the AI platform built for drug development — automating regulatory submissions, IND filings, and HAQ management. Based in San Francisco.
Funding and backers
Total raised
$30M
2 rounds on record
Latest round
$20M
Series A · Oct 2025 · 12 mo ago
Team
51-200
employees, estimated range
Hiring now
2
open roles
Backers
3
Ground Up Ventures, Innovation Endeavors
The money's age
Due for its next round
12 months since the last round · hiring slowed
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1
Partnership Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities · weave.bio
Nov 6, 2025
Launched Weave Bio Launches HAQ Manager, Extending AI-Native Regulatory Automation into Critical Review Phase · weave.bio
Oct 15, 2025
Raised a round Series A $20M
May 30, 2024
Raised a round Venture round $10M
Nov 2022
Website went live first capture in the Wayback Machine
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Oct 2025 | $20M | — | businesswire.com |
| Venture round | May 2024 | $10M | — | businesswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Ground Up Ventures 
Innovation Endeavors 
USVP Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About us Our mission is to help R&D teams go from idea to IND, 50% faster. Mithrl is built by scientists, for scientists.
Becoming is an AI and robotics research company building developmental intelligence, models that predict how organisms change over time…
Revolutionize drug development with AI-driven insights. Enhance portfolio strategy, reduce risks, and make informed decisions. Our…
We are automating scientific discovery. We build the models and the infrastructure for autonomous research.
Topos Bio is a drug discovery company that targets intrinsically disordered proteins in neurodegeneration, oncology and cardiometabolic…
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
Salary insights
Compensation ranges based on this company's open jobs
Median
$233k
Typical range
$165k – $300k
Open positions
2
2
Jobs
Staff
50%
Architect
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Staff | 1 | $165k | $165k |
| Architect | 1 | $300k | $300k |
Highest paying role
Head of Enterprise Sales
$300k
Normalized to USD per year
Growth
Hiring Momentum
25/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
Median time-to-fill
41 days
faster than 33% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
25% ▼
Solutions
25% ▲
Backend
13% ▲
Marketing
13% ▼
Operations
13% ▼
Customer Success
13% ▼
Tech stack
Technologies named in job postings at Weave Bio over the last 12 months, by layer, with the share of postings for each.
Technologies in use
8
Postings analysed
7
Stack modernity
79/100AI adopter
Languages
Python
Frameworks & libraries
Django
Databases
PostgreSQL
Redis
Cloud & platforms
Tableau
AI & ML
LLM
Sign in to see how your skills match this stack
Sign In
Full Weave Bio tech stack
8 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's Disease
MALVERN, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (
Read more
Report
Annovis Collaborates With Weave Bio On AI Use In NDA Submission For Butanetap
Annovis Bio Inc. (ANVS), a clinical-stage biotechnology company, on Wednesday announced a partnership with Weave Bio to advance its lead candidate Butanetap toward a New Drug Application (NDA).
Read more
Report
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
Weave Bio announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets. The collaboration brings together Weave's AI capabilities and Takeda's regulatory expertise to support innovation in regulat
Read more
Report
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
SAN FRANCISCO, September 01, 2026--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets. The collaborat
Read more
Report
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
Read more
Report
Two Former FDA Leaders Join Weave Bio's Strategic Advisory Board
We're expanding our Strategic Advisory Board with two former FDA leaders, Tala Fakhouri and Sean Khozin. Their guidance ensures Weave stays grounded in how regulators actually assess a submission, not in assumptions about it. View the press release The po
Read more
Report
Weave Bio Enables Global Submissions
Announcing new capabilities to power global submissions, including a pre-loaded EU CTA template and a custom template builder for any health authority worldwide. With Weave, teams can file everywhere from a single source of truth. View the press release T
Read more
Report
The Regulatory Expert Is Not Obsolete: Redefining Human Expertise in an AI-Accelerated Submission Environment
In this article featured in European Pharmaceutical Contractor's Spring 2026 issue, Weave CEO Brandon Rice shares his perspective on how AI is reshaping regulatory submissions and why human expertise matters more than ever. As AI takes on more of the draf
Read more
Report
Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle
Preparing an NDA has historically meant months of manual work. Weave's AI-native platform now handles the data extraction, authoring, content verification, and workflow automation behind that process. This frees regulatory teams to focus on strategic narr
Read more
Report
Weave Bio Establishes Inaugural Strategic Advisory Board
Weave Bio Strategic Advisory Board brings together leaders across pharma, academia, and capital markets to guide AI in regulatory science.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Francisco
San Francisco
United States
HQ
1 open roles 5 posted in 90 days 50-200 est. staff $300k Avg Salary
hires for Sales